Study: Medtronic renal denervation reduces blood pressure
Medtronic announced study data demonstrating significant blood pressure reduction with the Symplicity renal denervation system.
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic announced study data demonstrating significant blood pressure reduction with the Symplicity renal denervation system.
Medtronic, Edwards and Abbott presented positive data at TCT as TAVR, TEER and renal denervation innovations continue to arrive.
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
The trial failed to meet its primary endpoint, but benefits on disabling strokes muddy the waters for clinicians and patients regarding use of the Sentinel device.
Medtronic marked the start of the TCT 2022 conference today by announcing the full U.S. launch of its Evolut FX TAVR system.